Callan JMB, Inc. (CJMB)
NASDAQ:CJMB
Want to see CJMB full AI Analyst Report?
CJMB Stock Chart & Stats
$1.45
--
Market closed
$1.45
--
Day’s Range― - ―
52-Week Range$1.04 - $5.88
Previous CloseN/A
VolumeN/A
Average Volume (3M)10.79K
Market Cap
$6.19M
Enterprise Value$5.13M
Total Cash (Recent Filing)$2.13M
Total Debt (Recent Filing)$2.00M
Price to Earnings (P/E)―
Beta0.30
Next Earnings
May 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding5,627,368
10 Day Avg. Volume12,214
30 Day Avg. Volume10,793
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)2.09
Price to Sales (P/S)0.85
P/FCF Ratio-0.94
Enterprise Value/Market Cap0.83
Enterprise Value/Revenue0.90
Enterprise Value/Gross Profit2.43
Enterprise Value/Ebitda-0.66
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Sustained Gross MarginsMaintained gross margins in the high-30% range indicate the company’s core pricing and unit economics remain intact despite revenue loss. That structural resilience gives management a margin base to recover profitability if sales stabilize or fixed operating costs are realigned over the next several quarters.
Committed Equity Financing LineAn amended, ongoing equity purchase agreement with Hexstone extends committed access to capital and clarifies pricing/resale limits. This durable financing framework provides runway to execute a turnaround or cover cash shortfalls, reducing immediate liquidity stress though it may dilute existing shareholders over time.
Formalized Investor CommunicationsInstitutionalizing regular investor presentations and making materials publicly available improves transparency and outreach. Over months this can broaden investor interest, facilitate discussions with potential capital providers, and support more predictable access to funding and analyst coverage if results improve.
Bears Say
Nasdaq Equity Deficiency NoticeThe Nasdaq deficiency notice is a structural governance and listing risk: failure to regain required equity could lead to suspension or delisting. That outcome would materially reduce liquidity, raise capital costs, and impair long-term ability to attract financing or strategic partners if compliance is not restored.
Sharp Multi-year Revenue DeclineA steep decline in revenue over several years materially erodes scale and the company’s ability to cover fixed costs. Persistent top-line contraction signals potential loss of market share or demand and makes sustainable profitability harder to achieve without successful strategic change or renewed customer traction.
Material 2025 Cash Burn And Rising LeverageOperating and free cash flow swung to a material burn in 2025 while leverage increased and equity was eroded. This combination reduces financial flexibility, heightens reliance on external capital, increases dilution/default risk, and constrains investment in operations or growth absent swift improvement.
Callan JMB, Inc. News
CJMB FAQ
What was Callan JMB, Inc.’s price range in the past 12 months?
Callan JMB, Inc. lowest stock price was $1.04 and its highest was $5.88 in the past 12 months.
What is Callan JMB, Inc.’s market cap?
Callan JMB, Inc.’s market cap is $6.19M.
When is Callan JMB, Inc.’s upcoming earnings report date?
Callan JMB, Inc.’s upcoming earnings report date is May 14, 2026 which is in 24 days.
How were Callan JMB, Inc.’s earnings last quarter?
Currently, no data Available
Is Callan JMB, Inc. overvalued?
According to Wall Street analysts Callan JMB, Inc.’s price is currently Overvalued.
Does Callan JMB, Inc. pay dividends?
Callan JMB, Inc. does not currently pay dividends.
What is Callan JMB, Inc.’s EPS estimate?
Callan JMB, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Callan JMB, Inc. have?
Callan JMB, Inc. has 5,627,368 shares outstanding.
What happened to Callan JMB, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Callan JMB, Inc.?
Currently, no hedge funds are holding shares in CJMB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Callan JMB, Inc.
Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities. The company also provides perishable (non-pharma) client packaging, and technical services. The company was founded in 2006 and is headquartered in Spring Branch, Texas.
Technical Analysis
Singularity Future Technology
―
Addentax Group
―
PS International Group
―
Globavend Holdings Ltd.
―
New Century Logistics (BVI) Ltd.
―
Ownership Overview
56.53% Insiders
0.28% Mutual Funds
7.85% Other Institutional Investors
35.22% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---